Is a stool sample for a fecal calprotectin assay stable enough to be refrigerated and delivered to Quest Diagnostics on a Friday, or should it be collected and submitted on Monday?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Stool Sample Stability for Fecal Calprotectin Testing

Refrigerate the stool sample immediately and deliver it to Quest Diagnostics on Friday—calprotectin degrades significantly at room temperature within 24-48 hours, leading to falsely low results that may cause undertreatment.

Storage Temperature is Critical

The British Society of Gastroenterology explicitly recommends that stool samples be stored for no more than 3 days at room temperature before analysis, but this guideline predates more recent stability data showing faster degradation. 1

More recent research demonstrates that room temperature storage causes rapid calprotectin degradation:

  • After just 1 day at room temperature, calprotectin concentrations decline significantly from baseline (p < 0.001), with mean declines reaching 30-60% by day 4 depending on the assay used. 2
  • After 6 days at room temperature, mean calprotectin concentrations drop by 35% in untreated stool samples. 3
  • Refrigeration at 4°C significantly preserves calprotectin stability compared to room temperature storage (p = 0.0066). 3

Practical Recommendations for Your Patient

For Friday delivery:

  • Collect the first morning stool (this minimizes day-to-day variability). 1
  • Refrigerate immediately at 4°C after collection and keep refrigerated until delivery. 3, 2
  • Deliver to Quest Diagnostics on Friday as planned—refrigerated samples remain stable for at least 4 days. 2

If refrigeration is not possible:

  • Deliver the sample within 24 hours of collection to minimize degradation. 2
  • Be aware that even short delays at room temperature may produce falsely low results. 3, 2

Clinical Significance of Degradation

The stability issue has direct clinical consequences:

  • Children with IBD may be "falsely reassured by low calprotectin values" when samples degrade at room temperature, potentially leading to undertreatment. 3
  • The rate of decline varies between different calprotectin assays (30-60% decline after 4 days), making standardized pre-analytical handling essential. 2
  • Extracted feces in assay-specific extraction buffer also degrades at room temperature, with 46% mean decline after 6 days. 3

Why Monday Collection is Unnecessary

Refrigerated samples are stable for several days:

  • Calprotectin in untreated feces stored at 4°C does not show significant decline from baseline until after 4 days of storage. 2
  • One older study reported stability for up to 7 days at room temperature, but this conflicts with multiple recent studies showing degradation within 1-2 days—the more recent evidence should guide practice. 4, 3, 2

Common Pitfalls to Avoid

  • Never allow the sample to sit at room temperature for more than 24 hours—this produces clinically significant false-negative results. 3, 2
  • Do not assume all laboratories process samples immediately—weekend delivery may mean the sample sits until Monday, making refrigeration during transport essential. 2
  • Avoid freeze-thaw cycles if the patient attempts to freeze the sample—this is not recommended for routine calprotectin testing. 1

Bottom Line

Instruct your patient to refrigerate the stool sample immediately after collection and deliver it to Quest Diagnostics on Friday while keeping it cold during transport. This approach ensures accurate results without unnecessary delay in diagnosis or treatment decisions. 3, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the significance of a calprotectin level of 51 ug/g in a patient, potentially indicating gastrointestinal inflammation?
What does an elevated fecal calprotectin level indicate and how is it managed?
What does an elevated fecal calprotectin level indicate in a patient with diarrheal illness?
What is the treatment for elevated calprotectin (fecal calprotectin) levels in stool indicating gastrointestinal inflammation?
What is the likely diagnosis and treatment for a patient with chronic diarrhea for 1 month, elevated fecal calprotectin level, and no white blood cells (WBCs) in the stool?
In an older adult with low baseline muscle mass who is taking semaglutide for obesity, how can I monitor for sarcopenia and prevent loss of skeletal muscle while continuing therapy?
Is there evidence that glucagon‑like peptide‑1 (GLP‑1) receptor agonists (e.g., exenatide, liraglutide, dulaglutide) can reduce total daily insulin dose in overweight or obese adults with type 1 diabetes who have high insulin requirements?
In a neonate (<28 days) with a mild, localized umbilical stump infection and no systemic signs, can mupirocin 2% ointment be used as treatment, and what is the recommended dosing schedule?
How should an adult presenting with painless jaundice and markedly elevated bilirubin be evaluated and managed?
In a patient with pyogenic spondylodiscitis who is clinically improving (decreasing pain, stable or improving neurologic status, and falling C‑reactive protein), is repeat magnetic resonance imaging or computed tomography required to assess treatment response?
When can a 75‑year‑old man with Gleason 9 prostate cancer on abiraterone (abiraterone acetate), type 2 diabetes mellitus on insulin, who developed atrial fibrillation and acute heart failure, be considered for electrical or pharmacologic cardioversion?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.